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THE RIGHTS OF EMPLOYEES WITH AIDS:
THE CONFLICT BETWEEN THE NEED FOR
ADEQUATE INSURANCE COVERAGE AND
INDIVIDUAL PRIVACY IN THE
WORKPLACE
ROBERT E. STEIN*
I'm going to focus my discussion on four areas. Keeping in mind
the title of this conference, "Civil Rights for the Next Millennium:
Evolution of Employment Discrimination Under the Americans
with Disabilities Act," I will look ahead a bit.
The four areas that I will discuss are: the importance of access
to health care; workers' compensation and testing and confidenti-
ality; Human Immunodeficiency Virus ("HIV") vaccine issues re-
lated to the Americans with Disabilities Act ("ADA")1 and the at-
tendant insurance issues; and questions relating to the ADA
attorneys' fees and alternative dispute resolution ("ADR")
provisions.
Contrary to the belief of some, HIV is not that expensive a dis-
ease on a per capita basis compared to many other diseases.2 The
estimated cost per person for lifetime treatment of HIV and Ac-
quired Immune Deficiency Syndrome ("AIDS") is about $119,000.1
* Adjunct Professor at Georgetown Law Center, teaching "HIV Law Policy and Dispute
Resolution" for the past seven years; practicing attorney, arbitrator, and mediator in Wash-
ington, D.C. with the firm of Blicker & Stein; Vice-Chair, A.B.A. Coordinating Committee
on AIDS; B.A., Brandeis University, 1960; LL.B. Columbia Law School, 1963; and Diploma
of the Hague Academy of International Law, 1964.
1 42 U.S.C. §§ 12101-213 (Supp. V 1993).
2 William A. Bradford, Jr. et al., The AIDS Epidemic and Health Care Reform, 27 J.
MARSHALL L. REV. 279, 299 (1994). The authors explained that costs related to AIDS treat-
ment did not exceed those attached to other serious illnesses such as liver and heart dis-
ease, but also noted that comparative studies have not been completed. Id. Cf Daniel M.
Fox & Emily H. Thomas, THE CosT OF AIDS: EXAGGERATION, ENTrrLEMENT & ECONOMICS,
IN AIDS AND =HE HEALTH CARE SYSTEM 198 (Lawrence 0. Gostin ed., 1990) (discussing
health care industry's fear of enormous costs of AIDS treatment in early 1980s); Susan
Stabile, AIDS, Insurance and the ADA, 10 ST. JOHN'S J. LEGAL CoMMENT. 533 (1995).
3 Fred J. Hellinger, The Lifetime Cost of Treating a Person with HIV, 270 JAMA 474, 474
(1993). The estimated lifetime cost of treatment of an AIDS patient has climbed steadily
over the past five years, partially due to a longer life expectancy and the approval of new
drugs. Id.
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In contrast, the cost of treatment for many other diseases, disabil-
ities, and chronic conditions is much higher.4
Moreover, a recent survey done by the Health Insurance Associ-
ation of America ("HIAA") and the American Council of Life Insur-
ance ("ACLI") has concluded that in 1993, about 1.4 % of all claims
under individual and group health policies related to HIV and
AIDS.5 So, even though the number of cases is growing, HIV
claims are still not that significant a burden on the health and life
insurance industry.
Although the discussions about the Carparts6 decision and some
of the ERISA7 questions are very important and interesting ones,
parts of the topic of this Panel should not be taking place. As the
millennium approaches, we are one of the few developed countries
without a program of universal access to health care. This is not
just a problem for people with HIV, but for people with any kind of
serious illness.8 One of the problems with the current system is
that people with serious illnesses or disabilities, including HIV,
may not be employed. An employment-driven healthcare is not
going to cover a lot of people who could not get jobs, or who can no
longer work.9 The number of people in this country who are with-
out health insurance is approaching the number of people with
disabilities. They are not necessarily all the same people, but
thirty-two to thirty-seven million people without insurance cover-
age is still far too many.10
4 See Bradford, supra note 2, at 299-300.
5 American Council of Life Insurance, ACLI/HIAA AIDS Related Claims Survey: Claims
Paid in 1993, in AIDS REFERENCE GUME 316.
6 Carparts Distribution Ctr., Inc. v. Automotive Wholesaler's Ass'n, 37 F.3d 12, 28 (1st
Cir. 1994) (holding that defendant qualified as employer under ADA because actual em-
ployer had delegated to defendant its duty to provide insurance to its employees).
7 The Employer Retirement Income Security Act of 1974 ('ERISA"), 29 U.S.C. § 1001-
146 (1994). See generally, Lizzette Palmer, Comment, ERISA Preemption and Its Effects on
Capping the Health Benefits of Individuals with AIDS: A Demonstration of Why the United
States Health and Insurance Systems Require Substantial Reform, 30 Hous. L. REV. 1347,
1367-74 (1993); James R. Bruner, AIDS and ERISA Preemption: The Double Threat, 41
DUKE L.J. 1115, 1116 (1992).
8 Note, Universal Access to Health Care, 108 HARv. L. REv. 1323, 1325 (1995). Almost 40
million Americans were uninsured in 1993. Id.
9 Anna M. Rappaport, Policy Environment for Health Benefits: Implications for Em-
ployer Plans, 43 DEPAUL L. REV. 1107, 1107 (1994) (recognizing that gaps in health insur-
ance coverage exist where not all employers provide coverage and uninsured individuals do
not qualify for government assistance). But see Universal Access to Health Care, supra note
8, at 1325. "Although Americans rely considerably upon their employment for health in-
surance, employment-based coverage has decreased." Id.
10 Henry J. Aaron, Paying for Health Care, DoMESTIC AFFAIRS, Winter 1993, at 23. See
generally, Thomas Bodenheimer & Kevin Grumbach, Painful vs. Painless Cost Control, 272
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In a discussion of the ADA, AIDS and insurance questions, it
might be useful to look ahead to see what a person with an illness
such as HIV disease needs by way of insurance coverage. First,
we should look at the need for universal coverage. Second, we
should examine the need for comprehensive coverage which in-
cludes in-patient and out-patient hospital care, prescription
drugs, medical equipment, diagnostic and lab services, substance
abuse and mental health services, home health care and long-term
hospice care, which in many cases may be less expensive than hos-
pital care. The freedom of choice to select physicians with exper-
tise and affordable plans and co-payments with reasonable de-
ductibles is also important.
Within these categories, it is imperative to consider the particu-
lar needs of people with disabilities, especially those with HIV.
First, and I think this is very important, coverage of pre-existing
conditions and portability should be a part of any plan which is
adopted, so that an individual with HIV will not be precluded from
coverage if he or she takes a new job.
In a case involving the Rehabilitation Act, 1 which preceded the
ADA, a postal worker who was HIV-positive requested a transfer
from a post office in a small town to the larger city of Los Angeles
in order to secure better medical treatment. 12 The United States
Court of Appeals for the Ninth Circuit held that such a transfer is
a form of reasonable accommodation to be provided by the em-
ployer.13 The Postal Service has work sites all over the country,
but there may also be a person working in a town or city where he
or she cannot get medical treatment who might have to relocate to
a place where it is available. In those cases, if a person changes
jobs and loses insurance, a ban on coverage for pre-existing condi-
tions creates a difficult situation.
Second, insurance plans should provide adequate coverage for
prescription drugs, including access to experimental therapy.
Although newer classes of drugs may provide more beneifts, as the
JAMA 634, 634 (1994) (noting 1991 statistics on health care financing, including statistic
that 22% of all health care expenditures were out of pocket).
11 29 U.S.C. § 794 (1994).
12 Buckingham v. United States Postal Serv., 998 F.2d 735, 737 (9th Cir. 1993). Bucking-
ham was denied a transfer to Los Angeles because he was only employed by the Postal
Service for five and a half months. Id. Generally, employees needed a year tenure in order
to request to be transferred. Id.
13 Id. at 743.
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only drugs currently used to treat HIV have a limited success rate,
HIV patients need this additional protection. 14
Third, mental health and drug treatment benefits should be in-
cluded in insurance plans. These benefits were singled out in the
various plans which were raised in last year's debate over national
health insurance as being different from physical health benefits,
but they are necessary. Mental health and drug treatment bene-
fits are critical for the HIV community, especially with the in-
crease in the number of HIV cases among intravenous drug
users.15
In addition, coverage caps should not single out specific diseases
such as HIV or cancer. 16 Whatever caps exist should sufficiently
cover people with chronic conditions such as HIV and hemophilia.
Finally, confidentiality should be protected. This protection is
important not only to people with HIV, but also to those with
other conditions. Even if a person with HIV has insurance and
medical care, people have been denied individual health care
services. 17
This brings us back to a different aspect of Title III of the ADA.
In Morvant,18 the United States District Court for the Eastern
District of Louisiana granted summary judgment for the Justice
Department when it charged Morvant, a dentist, with improperly
denying services to a longstanding patient after the patient in-
formed Morvant that he was HIV positive. The dentist referred
the patient to another dentist claiming that the other dentist spe-
cialized in HIV positive patients.' 9 In fact, the other dentist was
14 See Kathryn S. Taylor, Fighting AIDS at Home: Hospitals, Physicians Seek Commu-
nity AIDS Strategies, Hosp., Jan. 20, 1994, at 52, 52-53 (discussing shift in focus from
traditional medical care for AIDS patients to services to enhance quality of life); 1995 U.S.
DEP'T. OF HEALTH & HUMAN SERVICES PUB. HEALTH REP. 110, 226 (citing $15 million study
launched to improve HIV-AIDS care).
15 See Center for Disease Control and Prevention, U.S. Dep't of Health and Human Serv-
ices, HIVIAIDS Surveillance Report (1994).
16 See EEOC INTERm ENFORCEMENT GUIDELINES IN THE APPLICATION OF THE ADA TO
DISABILITY-BASED DISTNCTIONS IN EMPLOYER-PROVIDED HEALTH INSURANCE (1993); see also
Carparts Distrib. Ctr., Inc. v. Automotive Wholesaler's Ass'n, 37 F.3d 12, 28 (1st Cir. 1994);
EEOC v. Gager, No. 94-CV-72089-DT (E.D. Mich. Consent Decree May 27, 1994).
17 See Bradford, supra note 2, at 291 (citing MICHAEL T. ISBELL, HEALTH CARE REFORM
LESSONS FROM THE HIV EPIDEMIC, 141 (1993)).
18 United States v. Morvant, 898 F. Sup.. 1157, 1159 (E.D. La. 1995) (stating that failure
to render dental services to known HIV-positive patient was clear violation of statute
which dentist did not rebut with sufficient evidence).
19 Id. at *7. The Court stated that:
[R]eferral because of the need for 'special' infection control precautions of persons with
HIV or AIDS is not appropriate. If dentists ... follow universal precautions in their
[Vol. 10:557
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not anymore of a specialist than Morvant. 20 The Morvant court
based its conclusion on the equal access to goods and services pro-
vision under Title III of the ADA.2 1 The remedies in Morvant were
also instructive: monetary damages, training about HIV for the
staff, and the posting of a sign in the office that services are pro-
vided to HIV positive patients.
There are other areas involving AIDS and insurance which, as
the millennium approaches, are going to become more important.
One issue is whether workers' compensation should be the exclu-
sive claim available to an employee. In those states where work-
ers' compensation is an exclusive remedy, should workers' com-
pensation be the exclusive remedy for those people who
occupationally contract HIV on the job?22 This is particularly per-
tinent to doctors and other health care professionals.
Consider when a person seeks treatment for a work-related in-
jury, such as a back problem, and tells the nurse to be careful ad-
ministering treatment to him because he is HIV positive. The
nurse then tells others, including the physician, and the informa-
tion eventually becomes part of the individual's medical record. It
then becomes part of his insurance record when it is reported to
the Medical Information Bureau. Is that considered a breach of
confidentiality? It is only tangentially related to workers' compen-
sation, but it is still related. The California court of appeals held
that such disclosure was inappropriate.23
A different kind of issue has come up in at least two cases.24
Strangely, both cases involved people who work in tire shops re-
practice, persons with HIV or AIDS or other blood-borne pathogens can be safely
treated in the dental setting.
Id.
20 Id.
21 Id. at *10.
22 See, e.g., Blythe v. Radiometer Am., Inc., 866 P.2d 218, 220 (Mont. 1993) (establishing
workers' compensation as exclusive remedy for exposure to AIDS virus in workplace); Val-
lery v. Southern Baptist Hosp., 630 So. 2d 861, 863 (La. Ct. App. 1993) (preventing recovery
for exposure to AIDS in workplace in excess of workers' compensation).
23 Urbaniak v. Newton, 277 Cal. Rptr.3d 354, 357 (Cal. Ct. App. 1991). Medical assist-
ants are required to keep HIV-positive status of patients confidential where such informa-
tion was provided by patient for sole purpose of taking safety precautions and not con-
nected to medical treatment sought. Id. The Court reasoned that Urbaniak "reasonably
anticipated privacy" when he disclosed his HIV-positive status to the nurse. Id. at 361.
Thus, the court chose to recognize such expectation to further the public interest of encour-
aging confidential communications in this area. Id.
24 See, e.g., Sacramona v. Bridgestone/Firestone, Inc., 152 F.R.D. 428, 428 (D. Mass.
1993) (seeking to force high-risk plaintiff to submit to HIV blood test in order to show de-
creased life expectancy in computing damages for future earnings); Pettyjohn v. Goodyear
1995]
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mounting tires. Where you have a work-related injury, and an in-
dividual claims it as part of his workers' compensation benefits, he
should be entitled to damages for loss of future earnings, diminu-
tion of future earning capacity, future medical costs, and future
disability costs. But is it appropriate to ask that individual to un-
dergo an HIV test? An HIV test, if positive, will be a determinant
of that individual's life span, and could influence the appropriate-
ness of an award for future damages.
In Pettyjohn v. Goodyear Tire & Rubber Co., the United States
District Court for the Eastern District of Pennsylvania concluded
that a defendant has a compelling need to know about the plain-
tiff's HIV-status because it is the plaintiff who brought the issue
of future damages into question.25 In Massachusetts, the United
States District Court for the Eastern District of Massachusetts
found that the plaintiff's HIV-status was not a relevant considera-
tion and did not require the plaintiff to be tested.2 6 In that case,
the court decided that the defendant could not cause information
to be created so that it then could be discovered.
Preventive vaccines present the problem of the possibility of a
false-positive result to an HIV-test. Though these vaccines are
not in expanded efficiency or Phase Three trials yet, they are in
use in clinical trials. Over 1600 people have been tested and are
undergoing part of safety and immunogenicity or Phase One and
Phase Two trials. A person participating in a clinical who takes a
vaccine in order to develop the desired immune response may
show positive antibodies on an Elisa or a Western Blot Test. This
false-positive result is an effect of the vaccine, not the presence of
the virus. 28
Tire & Rubber Co., No.91-CV-2681, 1992 WL 105162, at *1 (E.D. Pa. 1992) (seeking dam-
ages for future earnings due to personal injuries caused by explosion on job).
25 Pettyjohn, 1992 WL 105162, at *1.
26 Sacramona, 152 F.R.D. at 431-32 (reasoning that HIV status is in issue where it is
sought to prove liability but not for future damages).
27 Id.
28 See Robert E. Stein, Vaccine Liability and Participant Compensation Incentives in
HIV Vaccine Trials, in AIDS RESEARCH AND HuMAN RETROVIRUSES 5257 (Supp. 2 1994);
Robert E. Stein, Insurance and Liability Issues in the Development of an HIV Vaccine, 10
FOOD DRUG COSM. & MED. DEVIcE L. DIG. 80, 80 (1993); see also HIV Vaccinations to be
Evaluated in Field Trials, Hosp., June 5, 1994, at 26 (reporting contract in support of field
trials to test effectiveness of vaccines "to develop a safe and cost-effective vaccine for the
prevention of HIV infection").
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In the current environment, a false-positive result may cause
such person to suffer a range of social harms,29 including, but not
limited to, job termination, travel restrictions, blood donation re-
strictions and difficulty in obtaining health and life insurance be-
cause of that HIV test-a test that reflected an antibody status
due to a vaccine and not the virus. This fact places an obligation
on the administrators of the vaccine trials to provide appropriate
counseling to and secure informed consent from volunteers. It
also necessitates a careful understanding by insurance companies
of the issues involved. For example, since 1990, the National In-
stitutes of Health ("NIH"), which sponsors HIV vaccine trials, has
sent letters to insurance company associations to alert them to the
possibility that an individual taking a vaccine may have positive
antibodies under a normal reading of an Elisa or Western Blot
test.
Currently, it is possible to distinguish between vaccine induced
antibodies and viral-induced antibodies on a Western Blot read-
ing. That may become more complicated, but there are tests
which will distinguish viral antibodies from vaccines.
How does this relate to the ADA? The statute protects a person
with a physical or mental impairment, or who is regarded as hav-
ing an impairment. 30 Thus, a person with a test indicating posi-
tive antibodies due to a vaccine may be reported to state authori-
ties, pursuant to mandatory state reporting laws. That report
constitutes a record.
This situation has come up a number of times. Volunteers in
NIH trials are given tamper-proof cards which provides a toll- free
telephone number of the vaccine evaluation unit where the trial is
being conducted. This way an individual, at the same time as the
clinical trial center, provides an employer or insurer with more
information about the kind of vaccine being used in order to deter-
mine whether a positive result is due to the vaccine or an
infection.
29 See 1988 U.S. DEP'T. OF HEALTH & HUMAN SERV. PUB. HEALTH REP. 103, at 52-57.
30 42 U.S.C. § 12102(2) (Supp. V 1993). Section 12102(2) provides:
The term 'disability' means, with respect to an individual. .. (A) a physical or mental
impairment that substantially limits one or more of the major life activities of such
individual; or (B) a record of such impairment: or (C) being regarded as having such an
impairment.
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A card, however, does not and should not indicate that because
a person is participating in a trial, he or she is not HIV-positive
due to infection with the virus. Because we do not know yet what
the efficacy of the vaccine is going to be, it may be that an individ-
ual will take a vaccine in a clinical trial, and despite counseling,
engage in unsafe activities and contract the virus. This will be a
more prominent issue as vaccine trials increase.
As the millennium approaches, and we consider ways in which
the ADA can effectively handle some of the smaller problems
which lawyers may not want to take because there may not be a
large contingency fee involved, there are two sections of the ADA
that have not, but really should be, considered together.
One is the ADR section which encourages the use of alternative
dispute resolution,3 1 and the other is the attorneys' fee provi-
sion,32 which can provide fees to the prevailing party. Unless at-
torney fees can be provided to the prevailing party using an ADR
mechanism, few lawyers will take advantage of those approaches.
Instead, they will pursue litigation where they have the possibil-
ity of getting attorney's fees, although litigation may take longer
and be far more expensive.
Consider the McGann33 and Carparts3 4 cases. In both of these
cases, the plaintiff is the estate of the person who originally
brought the action. Litigation can take a very long time. There-
fore, it may be advantageous to consider using ADR mechanisms
including mediation and arbitration. Unless the issues of ADR
and attorneys' fees are considered together, ADR will remain
underutilized.
An historian, William McNeil, concluded in his book, Plagues
and Peoples, which reflected upon the historical relationship be-
31 42 U.S.C. § 12212 (Supp. V 1993). Section 12212 provides:
[Wihere appropriate and to the extent authorized by law, the use of alternative means
of dispute resolution, including settlement negotiations, conciliation, facilitation, medi-
ation, fact-finding, minitrials, and arbitration, is encouraged to resolve disputes aris-
ing under this Act.
Id.
32 42 U.S.C. § 12205 (1994). Section 12205 provides:
In any action or administrative proceeding commenced pursuant to this Act, the court
or agency, in its discretion, may allow the prevailing party, other than the United
States, a reasonable attorney's fee, including litigation expenses, and costs, and the
United States shall be liable for the foregoing the same as a private individual.
Id.
33 McGann v. H & H Music Co., 946 F. Supp. 401, 403 (5th Cir. 1991).
34 Carparts Distribution Ctr., Inc. v. Automotive Wholesaler's Ass'n, 37 F.3d 12, 28 (1st
Cir. 1994).
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tween a disease and society in history, that "infectious disease
which antedated the emergence of humankind will last as long as
humanity itself, will surely remain, as it has been hitherto, one of
the fundamental parameters in determinance of human his-
tory."35 Certainly HIV and the ADA and insurance fit within that
kind of conundrum.
35 Waj H. McNEILL, PLAGUES AND PEoPLE 257 (1976).
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